Evanthia Theodosiou Roussos Torres
NIH Rank #18517
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14675100Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2024
Linked Award Amount
$822.5K
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#18,517
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Evanthia Theodosiou Roussos Torres as a PI. Multi-PI records show the full award amount for context.
- 5R01CA283169-02R01Targeting myeloid suppression to enhance anti-tumor immunity in breast cancer$536.9Kaward amount
- 1P20CA290458-01P20The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer$285.6Kaward amount
Award organization
Organizations that administered FY2024 awards listing Evanthia Theodosiou Roussos Torres as a PI.
FY2024 award administered by University of Southern California (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Southern California
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Evanthia Theodosiou Roussos Torres.